| Hydroxychloroquine in Combination With Encorafenib and Cetuximab or Panitumumab in the Treatment of Metastatic BRAF-mutated Colorectal Cancer Refractory (NCT05576896) | Northwestern University | 2022-10-10 |
| Adjuvant mFOLFOXIRI vs. mFOLFOX6 in MRD Positive Stage II-III Colorectal Cancer (AFFORD) (NCT05427669) | Yanhong Deng | 2022-10-09 |
| Accuracy of Real Time Characterization in Artificial Intelligence-assisted Colonoscopy (NCT05754229) | Ismail Gögenur | 2022-10-01 |
| Exploratory Study on Combined Conversion Immunotherapy for Liver Metastasis of MSS Type Initial Unresectable Colorectal Cancer Based on Gene Status (NCT05409417) | Second Affiliated Hospital, Zhejiang University, School of Medicine | 2022-10-01 |
| The Role of Arginine in Oral Nutritional Supplementation in Preventing or Reducing Complications Following Colorectal Surgery in Patients Who Are Malnourished or at Risk of Malnutrition (NCT07506187) | University of Cadiz | 2022-10-01 |
| Role of IMP3 Expression in Colorectal Carcinoma: An Immunohistochemical Study (NCT05601388) | Sohag University | 2022-10-01 |
| Adenoma Detection Rate in Artificial Intelligence-assisted Colonoscopy (NCT05740137) | Ismail Gögenur | 2022-10-01 |
| A Study of the Possible Effects of Medication on Young Onset Colorectal Cancer (YOCRC) (NCT05568420) | Memorial Sloan Kettering Cancer Center | 2022-09-30 |
| GENOCARE: A Prospective, Randomized Clinical Trial of Genotype-Guided Dosing Versus Usual Care (NCT05391126) | Reema A. Patel | 2022-09-28 |
| A Study in People With Colorectal Cancer to Test Whether Ezabenlimab or Pembrolizumab in Combination With BI 765063 Lead to Side Effects or Delays in Surgery (NCT05446129) | Boehringer Ingelheim | 2022-09-27 |
| Intraoperative Indocyanine Green Fluorescence Angiography in Colorectal Surgery to Prevent Anastomotic Leakage (NCT05168839) | Centre Hospitalier Universitaire de Besancon | 2022-09-26 |
| COlorectal BReath Analysis (COBRA2) (NCT05844514) | Imperial College London | 2022-09-23 |
| Endocuff Enhanced Colonoscopy: Does it Improve Polyp Detection and Make Rectal Retroflexion Unnecessary (NCT05615857) | Hopital Montfort | 2022-09-22 |
| Comparison of the Physical Activity in Cancer Patients Assessed by Questionnaire and Motion Tracker (NCT05501379) | University Medicine Greifswald | 2022-09-21 |
| Leronlimab in Combination With Regorafenib in Patients With CCR5+, Metastatic Colorectal Cancer (NCT05730673) | CytoDyn, Inc. | 2022-09-20 |
| Optical Biopsy for Peritoneal Nodules in Colorectal Patients (NCT05879783) | Nanfang Hospital, Southern Medical University | 2022-09-15 |
| Natural Killer (NK) Cells in Combination With Interleukin-2 (IL-2) and Transforming Growth Factor Beta (TGFbeta) Receptor I Inhibitor Vactosertib in Cancer (NCT05400122) | David Wald | 2022-09-09 |
| CRC Detection Reliable Assessment With Blood (NCT05551052) | New Day Diagnostics | 2022-09-08 |
| Study of XL092 + Atezolizumab vs Regorafenib in Participants With Metastatic Colorectal Cancer (NCT05425940) | Exelixis | 2022-09-07 |
| Study of Dato-DXd as Monotherapy and in Combination With Anti-cancer Agents in Patients With Advanced Solid Tumours (TROPION-PanTumor03) (NCT05489211) | AstraZeneca | 2022-09-06 |
| Comparing the Effectiveness of Written Vs Verbal Advice for First Degree Relatives of Colorectal Cancer Patients (NCT06242197) | Ramathibodi Hospital | 2022-09-01 |
| Colorectal Cancer Screening in Cystic Fibrosis (NCT05362344) | University of Washington, the Collaborative Health Studies Coordinating Center | 2022-09-01 |
| Serial Gut Microbiome and Bacterial Gene Markers Changes After Endoscopic Resection of Colorectal Advanced Neoplasia (NCT05381792) | Chinese University of Hong Kong | 2022-09-01 |
| Comparative Study of Mitomycin and Lobaplatin in Advanced Colorectal Cancer Patients With Radical Surgery Combined With Hyperthermic Intraperitoneal Chemotherapy (NCT04845490) | Union Hospital, Tongji Medical College, Huazhong University of Science and Technology | 2022-09-01 |
| Diagnostic Value of Diffusion-weighted Magnetic Resonance in High-risk Colorectal and Appendiceal Neoplasms (NCT05623787) | Laval University | 2022-09-01 |
| Transversus Abdominis Plane Blocks With and Without Dexamethasone (NCT05432934) | University of Saskatchewan | 2022-09-01 |
| IMPROVE-pT1: Accurate Allocation of Completion Resection in Early Colorectal Cancer (NCT06040632) | University of Aarhus | 2022-09-01 |
| Neoadjuvant Encorafenib, Binimetinib and Cetuximab for Patients With BRAF V600E Mutated/pMMR Localized Colorectal Cancer (NCT05510895) | AIO-Studien-gGmbH | 2022-09-01 |
| The Effectiveness of Personalized Colorectal Cancer Screening Based on Fecal Hemoglobin Concentration (NCT05423886) | Esther Toes-Zoutendijk | 2022-09-01 |
| Real-Time CAD for Colonic Neoplasia: A RCT (NCT05963724) | Riverside University Health System Medical Center | 2022-09-01 |
| Sintilimab Combined With Regorafenib and HAIC in Patients With Colorectal Liver Metastasis (NCT05524155) | Tianjin Medical University Cancer Institute and Hospital | 2022-09-01 |
| Predicting Risk for Post-polypectomy Colorectal Cancer (NCT05606081) | Kaiser Permanente | 2022-09-01 |
| Phase 2 Study of DKN-01 in Colorectal Cancer (NCT05480306) | Leap Therapeutics, Inc. | 2022-08-30 |
| Impact of Preoperative Oral Branched-chain Amino Acids on Reducing Postoperative Insulin Resistance. (NCT05494658) | Sun Peng | 2022-08-26 |
| Anti-CEA CAR-T Cells to Treat Colorectal Liver Metastases (NCT05240950) | Changhai Hospital | 2022-08-25 |
| A Study of VS-6766 and Cetuximab in Patients With Advanced Colorectal Cancer (NCT05200442) | University of Chicago | 2022-08-22 |
| Evaluation of a Model for the Early Diagnosis of Colorectal Cancer by the Detection of 5-hydroxymethylcytosine (5-hmC) in Plasma Cell-free DNA to the Community Colorectal Cancer Screening Program (NCT05638243) | Fudan University | 2022-08-20 |
| A Study of IBI351 in Combination With Cetuximab in Subjects With KRAS G12C Mutated Metastatic Colorectal Cancer (NCT05497336) | Innovent Biologics (Suzhou) Co. Ltd. | 2022-08-18 |
| Use a Wearable Devices to Observe Complications of Mobilization for Colorectal Cancer After Surgery (NCT07289685) | Chang Gung Memorial Hospital | 2022-08-08 |
| Improving Care After Inherited Cancer Testing (NCT04763915) | Vanderbilt-Ingram Cancer Center | 2022-08-05 |
| A Study of Navicixizumab Monotherapy or in Combination in Patients With Select Advanced Solid Tumors (NCT05453825) | OncXerna Theraputics, Inc. | 2022-08-05 |
| Anti-CEACAM5 ADC M9140 in Advanced Solid Tumors (PROCEADE-CRC-01) (NCT05464030) | EMD Serono Research & Development Institute, Inc. | 2022-08-04 |
| Video Education With Result Dependent dIsclosure (NCT05225428) | Dana-Farber Cancer Institute | 2022-08-04 |
| Development and Validation of a Risk Prediction Model for Preoperative Frailty in Elderly Patients With Colorectal Cancer (NCT05879861) | Zunyi Medical College | 2022-08-01 |
| Integrative Omics Analysis for Colorectal Cancer and Metastasis (NCT05482529) | fan li | 2022-08-01 |
| LYL273 for Patients With Relapsed or Refractory mCRC (NCT05319314) | Lyell Immunopharma, Inc. | 2022-08-01 |
| Molecular Effects of Aspirin & Metformin on Colonic Epithelium (NCT05158374) | University of Edinburgh | 2022-08-01 |
| A Dose Escalation Study of HBI-2438 in Patients With Solid Tumors Harboring KRAS G12C Mutation (NCT05485974) | HUYABIO International, LLC. | 2022-08-01 |
| The Deep South Surgical Equity Research Network: Addressing Socioecological Determinants of Health (NCT05345054) | University of Alabama at Birmingham | 2022-08-01 |
| Prospective Multicenter Registry Study to Assess the Frequency of Lynch Syndrome Among Patients With Colorectal Cancer (NCT05495776) | State Scientific Centre of Coloproctology, Russian Federation | 2022-08-01 |
| The BurnAlong Pilot Study for Adolescent and Young Adult Cancer Survivors (NCT05131815) | Cedars-Sinai Medical Center | 2022-07-25 |
| Microbiome, Immune-system and Tumor Interaction in Colorectal Cancer (NCT06331988) | European Institute of Oncology | 2022-07-21 |
| Prevention of Oxaliplatin-induced Nerve Damage in the Body's Extremities (NCT05404230) | Vejle Hospital | 2022-07-15 |
| The Effect of a Mobile Application on Patient Outcomes in Colorectal Cancer Patients (NCT05813028) | Ankara University | 2022-07-15 |
| PD-L2 Targeting Nanobody Radiotracer for PET Imaging of Solid Tumor (NCT05803746) | Peking University Cancer Hospital & Institute | 2022-07-15 |
| The Effect of Oral Carbohydrate Administration on Postoperative Well-being (NCT05402592) | Muğla Sıtkı Koçman University | 2022-07-13 |
| FAPI PET/CT for Lymph Node Staging in Colorectal Carcinoma (NCT05209750) | The Netherlands Cancer Institute | 2022-07-13 |
| FAPi Radioligand OpeN-Label, Phase 1 Study to Evaluate Safety, Tolerability and DosImetry of [Lu-177]-PNT6555; A Dose Escalation Study for TReatment of Patients With Select Solid Tumors (FRONTIER) (NCT05432193) | POINT Biopharma, a wholly owned subsidiary of Eli Lilly and Company | 2022-07-13 |
| Patient Outcomes After Hepatic Artery Infusion Pump Placement (NCT05468593) | Mayo Clinic | 2022-07-12 |
| Fruquintinib Combined With Tislelizumab and HAIC in Patients With Advanced Colorectal Liver Metastases Cancer Who Failed Standard Therapy (NCT05435313) | Fudan University | 2022-07-12 |
| A Prospective Cohort Study on Colorectal Cancer Screening in Community Population (NCT05485077) | Singlera Genomics Inc. | 2022-07-09 |
| Study for the Multidimensional Analyses of Resistance and Toxicity to Immune- and Targeted-therapies. (NCT06321640) | European Institute of Oncology | 2022-07-08 |
| Project CADENCE (CAncer Detected Early caN be CurEd) (NCT05633342) | MiRXES Pte Ltd | 2022-07-07 |
| Evaluation of Nexpowder Application to Prevent Delayed Bleeding After Colorectal Endoscopic Mucosal Resection (NCT05247515) | Gabriel RAHMI | 2022-07-01 |
| Fruquintinib Plus Capecitabine Versus Capecitabine as Maintenance Therapy for Metastatic Colorectal Cancer After First-line Chemotherapy (NCT05451719) | Fudan University | 2022-07-01 |
| The Argentina Brief Colonoscopy Difficulty Score (ABCD) (NCT05422820) | Institute of Gastroenterology and Advance Endoscopy | 2022-07-01 |
| The Colorectal Cancer Chemoprevention Acceleration and Improvement Platform (CRC-CHAMP) Study (NCT05402124) | University of Calgary | 2022-07-01 |
| ARGONAUT: Stool and Blood Sample Bank for Cancer Patients (NCT04638751) | Persephone Biosciences | 2022-07-01 |
| Web-based Learning Module on Optical Diagnosis of Early Colorectal Cancer (NCT05663788) | Althaia Xarxa Assistencial Universitària de Manresa | 2022-07-01 |
| Microbiome in Colorectal Cancer Onset and Progression (NCT05368688) | Viome | 2022-06-30 |
| Safety and Pharmacokinetics of Tucatinib (MK-7119) in Chinese Participants With Cancer (MK-7119-002) (NCT05382364) | Pfizer | 2022-06-29 |
| Diagnostic Accuracy of a Panel of Bacterial Gene Markers (M3) for Colorectal Advanced Neoplasia (NCT05405673) | Chinese University of Hong Kong | 2022-06-29 |
| Pre- and Post-operative TEG Indices in Patients With or Without Adenocarcinoma Undergoing Surgical Resection (NCT05517811) | University of Colorado, Denver | 2022-06-26 |
| Marathon of Hope Cancer Centres Network Study for Ontario (MOHCCN-O) (NCT05403177) | University Health Network, Toronto | 2022-06-23 |
| A Phase 1/2 Trial of TC-510 In Patients With Advanced Mesothelin-Expressing Cancer (NCT05451849) | TCR2 Therapeutics | 2022-06-21 |
| A Study of SOT101 in Combination With Pembrolizumab to Evaluate the Efficacy and Safety in Patients With Selected Advanced Solid Tumors (NCT05256381) | SOTIO Biotech AG | 2022-06-21 |
| Tempus CRC Surveillance Study: A ctDNA Biomarker Profiling Study of Patients With CRC Using NGS Assays (NCT05234177) | Tempus AI | 2022-06-21 |
| Application of Polygenic Methylation Markers in Postoperative Recurrence Monitoring of Colorectal Cancer (NCT05444491) | Singlera Genomics Inc. | 2022-06-20 |
| Increasing Uptake of Bowel Screening (NCT05408169) | University of Glasgow | 2022-06-20 |
| Colonoscopy Outreach for Rural Communities Aim 2 (NCT05453630) | University of Washington | 2022-06-16 |
| Effects of Red Ginseng on Gastrointestinal Symptoms and Microbiota After Surgery for Gastrointestinal Cancer (NCT06561516) | Gangnam Severance Hospital | 2022-06-14 |
| A Study of Coformulated Favezelimab/Pembrolizumab (MK-4280A) Versus Standard of Care in Subjects With Previously Treated Metastatic PD-L1 Positive Colorectal Cancer (MK-4280A-007)-China Extension Study (NCT05600309) | Merck Sharp & Dohme LLC | 2022-06-14 |
| A Phase 1 in Patients With HLA-A*0201+ and WT1+ Recurrent/Metastatic Cancers (NCT05360680) | Cue Biopharma | 2022-06-14 |
| Effect of FMD on Colorectal Cancer Patients (NCT05384444) | Fudan University | 2022-06-08 |
| A First-in-human Study to Evaluate the Safety and Tolerability of AZD8853 in Participants With Selected Advanced/Metastatic Solid Tumours (NCT05397171) | AstraZeneca | 2022-06-07 |
| TAS-102 With or Without Celecoxib in ctDNA-defined Minimal Residual Disease in Colorectal Cancer After Completion of Adjuvant Chemotherapy (NCT05343013) | M.D. Anderson Cancer Center | 2022-06-06 |
| ASPIRED-XT: ASPirin Intervention for the REDuction of Colorectal Cancer Risk -EXTension (NCT05056896) | Massachusetts General Hospital | 2022-06-03 |
| Preoperative Systemic Therapy for Colorectal Cancer Peritoneal Metastases (NCT05353582) | Sun Yat-sen University | 2022-06-01 |
| Reinforced Versus Conventional Anastomosis in Laparoscopic Low Rectal Cancer Resection: A Comparative Study (NCT07346534) | Shanghai 10th People's Hospital | 2022-06-01 |
| Dynamics of MSI and Genomic Profile of Colorectal Cancer In the Course of Immune Checkpoint Inhibitor Therapy (NCT06414304) | OncoAtlas LLC | 2022-06-01 |
| Phase 1 Study of BPI-442096 in Advanced Solid Tumor Patients (NCT05369312) | Betta Pharmaceuticals Co., Ltd. | 2022-06-01 |
| Mucosa Adherent Intestinal Microbiome in Microscopic Colitis and Colorectal Cancer (NCT06172647) | Hospital Mutua de Terrassa | 2022-06-01 |
| Appendectomy and Colorectal Cancer (NCT06091137) | Chinese University of Hong Kong | 2022-06-01 |
| Polyprev: Study to Compare Fecal Immunochemical Test With Endoscopic Surveillance After Advanced Adenoma Resection in Fecal Immunochemical Test Colorectal Cancer Screening Programs. (NCT04967183) | Fundacin Biomedica Galicia Sur | 2022-06-01 |
| Early Discharge After Robotic Colorectal Surgery (eRCS): a Prospective Observational Study (NCT05408182) | Ospedale di Camposampiero | 2022-06-01 |
| FT536 Monotherapy and in Combination With Monoclonal Antibodies in Advanced Solid Tumors (NCT05395052) | Fate Therapeutics | 2022-05-31 |
| Mailed FIT Outreach 2022 (NCT05341622) | Abramson Cancer Center at Penn Medicine | 2022-05-27 |
| A Clinical Study of CEA-targeted CAR-T in the Treatment of CEA-positive Advanced Malignant Solid Tumors (NCT05396300) | Weijia Fang, MD | 2022-05-25 |
| The Correlation of a D-dimer Testing Protocol With Venous Thromboembolism in Surgical Colorectal Patients (NCT05246943) | The University of Texas Medical Branch, Galveston | 2022-05-25 |
| Effect of Exercise on Bowel Function in Colorectal Cancer Survivors (NCT05420870) | Yonsei University | 2022-05-23 |